Uncoupling proteins and non-alcoholic fatty liver disease

Journal of Hepatology

Volumn 50, Issue 5, 2009, Pages 857-860

  Cortez Pinto, Helena ^a   Machado, Mariana V ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3;

CANCER RISK; CELL FATE; EDITORIAL; FATTY ACID OXIDATION; FATTY LIVER; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER MITOCHONDRION; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; FATTY ACIDS; FATTY LIVER; HUMANS; MITOCHONDRIAL PROTEINS; REACTIVE OXYGEN SPECIES;

EID: 64749116935     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.02.019     Document Type: Editorial

References (35)

1. Cortez-Pinto H., de Moura M.C., and Day C.P. Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol 44 (2006) 197-208
2. Ibdah J.A., Perlegas P., Zhao Y., Angdisen J., Borgerink H., Shadoan M.K., et al. Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. Gastroenterology 128 (2005) 1381-1390
3. Perez-Carreras M., Del Hoyo P., Martin M.A., Rubio J.C., Martin A., Castellano G., et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38 (2003) 999-1007
4. Yang S., Zhu H., Li Y., Lin H., Gabrielson K., Trush M.A., et al. Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys 15 (2000) 259-268
5. Hensley K., Kotake Y., Sang H., Pye Q.N., Wallis G.L., Kolker L.M., et al. Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis 21 (2000) 983-989
6. Pessayre D., and Fromenty B. NASH: a mitochondrial disease. J Hepatol 42 (2005) 928-940
7. Wei Y., Rector R.S., Thyfault J.P., and Ibdah J.A. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 14 (2008) 193-199
8. Fleury C., Neverova M., Collins S., Raimbault S., Champigny O., Levi-Meyrueis C., et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15 (1997) 269-272
9. Brand M.D. The proton leak across the mitochondrial inner membrane. Biochim Biophys Acta 1018 (1990) 128-133
10. Sluse F.E., Jarmuszkiewicz W., Navet R., Douette P., Mathy G., and Sluse-Goffart C.M. Mitochondrial UCPs: new insights into regulation and impact. Biochim Biophys Acta 1757 (2006) 480-485
11. Larrouy D., Laharrague P., Carrera G., Viguerie-Bascands N., Levi-Meyrueis C., Fleury C., et al. Kupffer cells are a dominant site of uncoupling protein 2 expression in rat liver. Biochem Biophys Res Commun 235 (1997) 760-764
12. Taniguchi E., Harada M., Kawaguchi T., Koga H., Kumemura H., Hanada S., et al. Expression of uncoupling protein-2 in biliary epithelial cells in primary biliary cirrhosis. Liver 22 (2002) 451-458
13. Tan M.G., Ooi L.L., Aw S.E., and Hui K.M. Cloning and identification of hepatocellular carcinoma down-regulated mitochondrial carrier protein, a novel liver-specific uncoupling protein. J Biol Chem 279 (2004) 45235-45244
14. 2 levels: A novel mechanism for NAFLD. J Hepatol 50 (2009) 1019-1028
15. MacLellan J.D., Gerrits M.F., Gowing A., Smith P.J., Wheeler M.B., and Harper M.E. Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells. Diabetes 54 (2005) 2343-2350
16. Schrauwen P., Hardie D.G., Roorda B., Clapham J.C., Abuin A., Thomason-Hughes M., et al. Improved glucose homeostasis in mice overexpressing human UCP3: a role for AMP-kinase?. Int J Obes Relat Metab Disord 28 (2004) 824-828
17. Baffy G. Uncoupling protein-2 and non-alcoholic fatty liver disease. Front Biosci 10 (2005) 2082-2096
18. Carling D. The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem Sci 29 (2004) 18-24
19. Sheets A.R., Fulop P., Derdak Z., Kassai A., Sabo E., Mark N.M., et al. Uncoupling protein-2 modulates the lipid metabolic response to fasting in mice. Am J Physiol 294 (2008) G1017-G1024
20. Chavin K., Yang S., Lin H.Z., Chatham J., Chacko V.P., Hoek J.B., et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 274 (1999) 5692-5700
21. Ribeiro P.S., Cortez-Pinto H., Sola S., Castro R.E., Ramalho R.M., Baptista A., et al. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 99 (2004) 1708-1717
22. Rashid A., Wu T.C., Huang C.C., Chen C.H., Lin H.Z., Yang S.Q., et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29 (1999) 1131-1138
23. Baffy G., Zhang C.Y., Glickman J.N., and Lowell B.B. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 35 (2002) 753-761
24. Cortez-Pinto H., Lin Z.L., Yang S.Q., Costa S.O., and Diehl A.M. Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes. Gastroenterology 116 (1999) 1184-1193
25. Jezek P. Possible physiological roles of mitochondrial uncoupling proteins - UCPn. Int J Biochem Cell Biol 34 (2002) 1190-1206
26. Cortez-Pinto H., Chatham J., Chacko V.P., Arnold C., Rashid A., and Diehl A.M. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 282 (1999) 1659-1664
27. Evans Z.P., Ellett J.D., Schmidt M.G., Schnellmann R.G., and Chavin K.D. Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion. J Biol Chem 283 (2008) 8573-8579
28. Fulop P., Derdak Z., Sheets A., Sabo E., Berthiaume E.P., Resnick M.B., et al. Lack of UCP2 reduces Fas-mediated liver injury in ob/ob mice and reveals importance of cell-specific UCP2 expression. Hepatology 44 (2006) 592-601
29. Lee F.-Y., Li Y., Yang E.K., Yang S.Q., Lin H.Z., Trush M.A., et al. Phenotypic abnormalities in macrophages from leptin-deficient, obese mice. Am J Physiol 276 (1999) C386-C394
30. Lin H.Z., Yang S.Q., Chuckaree C., Kuhajda F., Ronnet G., and Diehl A.M. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 6 (2000) 998-1003
31. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B., et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37 (2003) 343-350
32. Collins P., Jones C., Choudhury S., Damelin L., and Hodgson H. Increased expression of uncoupling protein 2 in HepG2 cells attenuates oxidative damage and apoptosis. Liver Int 25 (2005) 880-887
33. Vincent A.M., Olzmann J.A., Brownlee M., Sivitz W.I., and Russell J.W. Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. Diabetes 53 (2004) 726-734
34. Franco R., Sanchez-Olea R., Reyes-Reyes E.M., and Panayiotidis M.I. Environmental toxicity, oxidative stress and apoptosis: menage a Trois. Mutat Res (2008)
35. Feldstein A.E., Canbay A., Angulo P., Taniai M., Burgart L.J., Lindor K.D., et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125 (2003) 437-443